![Lin Ni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lin Ni
Directeur/Membre du Conseil chez
TENNOR THERAPEUTICS (SUZHOU) LIMITED
Profil
Lin Ni is currently the Managing Director at 6 Dimensions Capital since 2017 and an Independent Non-Executive Director at TenNor Therapeutics Suzhou Ltd. starting in 2025.
Former positions include Managing Director at Frontline Bioventures, Director at Shanghai Ark Biopharmaceutical Co., Ltd. in 2021, and Non-Executive Director at Edding Genor Group Holdings Ltd. from 2021 to 2022.
Education includes a doctorate degree from Osaka University conferred in 2009.
Postes actifs de Lin Ni
| Sociétés | Poste | Début |
|---|---|---|
| TENNOR THERAPEUTICS (SUZHOU) LIMITED | Directeur/Membre du Conseil | 08/07/2025 |
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital invests in early and growth stage companies in China, the U.S. and globally. The firm focuses on sectors such as biologics, small molecules, medical devices, diagnostics, medical services and healthcare IT. | Private Equity Investor | 18/05/2017 |
Anciens postes connus de Lin Ni
| Sociétés | Poste | Fin |
|---|---|---|
| EDDING GENOR GROUP HOLDINGS LIMITED | Directeur/Membre du Conseil | 29/07/2022 |
Frontline Bioventures
 Frontline Bioventures Investment ManagersFinance Acts as an alternative investment manager | Directeur/Membre du Conseil | 18/05/2017 |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. BiotechnologyHealth Technology Develops drugs and biopharmaceuticals for respiratory diseases | Directeur/Membre du Conseil | - |
Formation de Lin Ni
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Osaka University
 Osaka University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frontline Bioventures
Frontline Bioventures Investment ManagersFinance Acts as an alternative investment manager | Finance |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital invests in early and growth stage companies in China, the U.S. and globally. The firm focuses on sectors such as biologics, small molecules, medical devices, diagnostics, medical services and healthcare IT. | Finance |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. BiotechnologyHealth Technology Develops drugs and biopharmaceuticals for respiratory diseases | Health Technology |
TenNor Therapeutics Suzhou Ltd.
 TenNor Therapeutics Suzhou Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which engages in discovery, development and commercialization of therapies for bacterial infections and metabolism | Health Technology |
Genor Biopharma Holdings Ltd.
 Genor Biopharma Holdings Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes oncology and autoimmune drugs | Health Technology |
